SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-381215"
 

Search: onr:"swepub:oai:DiVA.org:uu-381215" > Handling interoccas...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Abrantes, João A.Uppsala universitet,Institutionen för farmaceutisk biovetenskap (author)

Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • 2019-04-29
  • John Wiley & Sons,2019
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-381215
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-381215URI
  • https://doi.org/10.1111/bcp.13901DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • AIMS: This study aims to assess approaches to handle interoccasion variability (IOV) in a model-based therapeutic drug monitoring (TDM) context, using a population pharmacokinetic model of coagulation factor VIII as example.METHODS: We assessed five model-based TDM approaches: empirical Bayes estimates (EBEs) from a model including IOV, with individualized doses calculated based on individual parameters either (i) including or (ii) excluding variability related to IOV; and EBEs from a model excluding IOV by (iii) setting IOV to zero, (iv) summing variances of interindividual variability (IIV) and IOV into a single IIV term, or (v) re-estimating the model without IOV. The impact of varying IOV magnitudes (0-50%) and number of occasions/observations was explored. The approaches were compared with conventional weight-based dosing. Predictive performance was assessed with the prediction error (PE) percentiles.RESULTS: When IOV was lower than IIV, the accuracy was good for all approaches (50th percentile of the PE [P50] <7.4%), but the precision varied substantially between IOV magnitudes (P97.5 61-528%). Approach (ii) was the most precise forecasting method across a wide range of scenarios, particularly in case of sparse sampling or high magnitudes of IOV. Weight-based dosing led to less precise predictions than the model-based TDM approaches in most scenarios.CONCLUSIONS: Based on the studied scenarios and theoretical expectations, the best approach to handle IOV in model-based dose individualisation is to include IOV in the generation of the EBEs, but exclude the portion of unexplained variability related to IOV in the individual parameters used to calculate the future dose.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Jönsson, Siv,1963-Uppsala universitet,Institutionen för farmaceutisk biovetenskap(Swepub:uu)sivjonss (author)
  • Karlsson, MatsUppsala universitet,Institutionen för farmaceutisk biovetenskap(Swepub:uu)matskarl (author)
  • Nielsen, Elisabet I.,1973-Uppsala universitet,Institutionen för farmaceutisk biovetenskap(Swepub:uu)elnie838 (author)
  • Uppsala universitetInstitutionen för farmaceutisk biovetenskap (creator_code:org_t)

Related titles

  • In:British Journal of Clinical Pharmacology: John Wiley & Sons85:6, s. 1326-13360306-52511365-2125

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Abrantes, João A ...
Jönsson, Siv, 19 ...
Karlsson, Mats
Nielsen, Elisabe ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Basic Medicine
and Pharmacology and ...
Articles in the publication
British Journal ...
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view